文献速递肝病

脂肪组织I型干扰素信号可预防代谢功能障碍

Adipose type I interferon signalling protects against metabolic dysfunction.
PubMed 文献 · Gut · 2016-12-23

该研究通过组织特异性敲除I型干扰素受体1(Ifnar1)的小鼠模型,探讨脂肪、肝细胞、髓细胞及肠上皮细胞I型干扰素信号在高脂或MCD饮食诱导的代谢紊乱和肝脏疾病中的作用,并分析肥胖患者减重手术后I型干扰素调节基因的表达。

要点

  • 脂肪细胞特异性缺失Ifnar1加重高脂饮食诱导的体重增加、胰岛素抵抗和糖耐量受损。
  • 肝细胞特异性缺失Ifnar1加重MCD饮食诱导的脂肪变性和炎症。
  • 肥胖患者LAGB术后代谢改善与皮下脂肪和肝脏I型干扰素调节基因表达增加相关。

核心结论

  • 脂肪组织和肝细胞I型干扰素信号在饮食诱导的代谢紊乱和肝脏疾病中发挥作用。
  • 作者认为需要进一步研究I型干扰素信号在代谢疾病中的作用。

研究设计与样本

  • 研究通过组织特异性敲除Ifnar1的小鼠模型,分别于肝细胞(Ifnar1Δhep)、脂肪细胞(Ifnar1Δat)、肠上皮细胞(Ifnar1ΔIEC)或髓细胞(Ifnar1Δmyel)中缺失I型干扰素信号,并给予高脂或蛋氨酸胆碱缺乏(MCD)饮食。
  • 研究还检测了接受腹腔镜可调节胃束带术(LAGB)的肥胖患者I型干扰素调节基因的表达。

主要发现

  • 长链脂肪酸诱导小鼠肝细胞和巨噬细胞产生I型干扰素反应,高脂饮食引起野生型小鼠肝脏I型干扰素调节基因表达。
  • 肝细胞特异性而非脂肪组织特异性缺失Ifnar1加重MCD饮食诱导的脂肪变性和炎症。
  • 脂肪组织特异性而非肝细胞特异性缺失Ifnar1加重高脂饮食诱导的体重增加、胰岛素抵抗和糖耐量受损。
  • 髓细胞或肠上皮细胞中阻断I型干扰素信号未调节对代谢或肝脏疾病的易感性。
  • 肥胖患者LAGB术后代谢控制改善与皮下脂肪组织和肝脏中I型干扰素调节基因表达增加相关。

局限性

  • 原文结论指出需要进一步研究I型干扰素信号在代谢疾病中的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Low-grade chronic inflammation emerges as a potent driver of insulin resistance and glucose dysregulation in obesity and associated non-alcoholic fatty liver disease (NAFLD). The liver, subcutaneous fat and the immune system participate in disturbances of metabolism. Type I interferon (IFN) signalling initiated by innate and adaptive immunity modulates inflammatory responses consequent to infection. However, little is known about the role of type I IFN signalling in metabolic diseases and the development of NAFLD. DESIGN: We determined the impact of type I IFN signalling by tissue-specific deletion of interferon (α and β) receptor 1 (Ifnar1) in hepatocytes (Ifnar1Δhep ), adipocytes (Ifnar1Δat ), intestinal epithelial cells (Ifnar1ΔIEC ) or myelocytes (Ifnar1Δmyel ) on glucose metabolism, obesity and hepatic disease in mice exposed to a high-fat or methionine-choline-deficient (MCD) diet. Furthermore, we investigated the expression of type I IFN-regulated genes in patients with obesity undergoing laparoscopic adjustable gastric banding (LAGB). RESULTS: Long chain fatty acids induce type I IFN responses in murine hepatocytes and macrophages and exposure to a high-fat diet elicited type I IFN-regulated gene expression in the liver of wild-type mice. Hepatocyte-specific, but not adipose tissue-specific deletion of Ifnar1 worsened steatosis and inflammation induced by the MCD diet. In contrast, adipose-specific, but not hepatocyte-specific deletion of Ifnar1 deteriorated metabolic dysregulation induced by a high-fat diet, indicated by increased weight gain, insulin resistance and an impaired glucose tolerance. Abrogated type I IFN signalling in myeloid or intestinal epithelial cells did not modulate susceptibility to metabolic or hepatic disease. Improved metabolic control in patients with obesity after LAGB was associated with increased expression of type I IFN-regulated genes in subcutaneous adipose tissue and liver. CONCLUSIONS: Our study implicates a role for adipose and hepatocyte type I IFN signalling in diet-induced metabolic dysregulation and hepatic disease. Further studies on type I IFN signalling in metabolic diseases are warranted.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Wieser V, Adolph TE, Grander C, et al. Adipose type I interferon signalling protects against metabolic dysfunction. Gut. 2016. PMID: 28011892. doi:10.1136/gutjnl-2016-313155

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。